Simpson, Fiona C. http://orcid.org/0000-0003-3534-050X
McTiernan, Christopher D.
Islam, Mohammad Mirazul
Buznyk, Oleksiy http://orcid.org/0000-0002-5534-6258
Lewis, Philip N.
Meek, Keith M.
Haagdorens, Michel
Audiger, Cindy
Lesage, Sylvie http://orcid.org/0000-0002-0968-2795
Gueriot, François-Xavier
Brunette, Isabelle http://orcid.org/0000-0003-1813-4528
Robert, Marie-Claude
Olsen, David
Koivusalo, Laura http://orcid.org/0000-0001-5639-8220
Liszka, Aneta
Fagerholm, Per
Gonzalez-Andrades, Miguel
Griffith, May http://orcid.org/0000-0003-1222-6720
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (391487)
RCUK | Medical Research Council (MR/S037829/1)
Caroline Durand Foundation University de Montreal FROUM ISCIII-ERDF/ES
Article History
Received: 17 July 2020
Accepted: 16 March 2021
First Online: 21 May 2021
Competing interests
: M.G. is a named inventor on PCT patents WO2007/028258 A2 Interpenetrating networks, and related methods and compositions, assigned to the Ottawa Hospital Research Institute and University of Ottawa; PCT/IB2017/056342 Collagen and CLP-based hydrogels, corneal implants, filler glue and uses thereof, which was assigned to the Hyderabad Eye Research Foundation, and then subsequently assigned to North Grove Investments, Inc. wherein PCT national phase applications have been filed in the USA, EU, India, China, and Canada. C.D.M. and M.G. are named inventors on a US provisional patent application no. 62916765, subsequent to a disclosure to Univalor, technology transfer agent to Maisonneuve-Rosemont Hospital and Université de Montréal. There are no other competing interests from other co-authors.